Condition: Bronchiectasis Adult · Bronchiectasis With Pseudomonas Aeruginosa Colonization · Bacterial Infections · Sponsor: Centauri Therapeutics Limited
The primary objective of this trial is to assess the safety and tolerability of single and multiple ascending intravenously (IV) infused doses of CTX-187 when administered to healthy adult male and female participants and participants with a bacterial infection (bronchiectasis participants chronically infected with P. aeruginosa).
This description comes directly from the study's public registry record.
Centauri Clinical Team · Please use email · clinical@centauritherapeutics.com
Always discuss trial participation with your own doctor first.
| ICON Clinic, location GRQM | Groningen, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07708116